A 70-year-old man with diabetes, hypertension, and chronic kidney disease (eGFR 35 mL/min/1.73m²) presents with NSTEMI. Troponin is elevated at 8.5 ng/mL. ECG shows 2mm ST depression in V2-V5. GRACE score is 165 (high risk). He is hemodynamically stable. Cardiologist recommends early invasive strategy within 24 hours. Nephrologist is concerned about contrast-induced nephropathy potentially requiring dialysis. Patient is on metformin. Evaluate the management strategy integrating multiple specialist perspectives and evidence.
Q2
A 58-year-old woman with anterior STEMI underwent primary PCI with drug-eluting stent placement. Post-procedure echocardiogram shows left ventricular ejection fraction of 30% with apical akinesis. She is started on aspirin, ticagrelor, high-intensity statin, and ACE inhibitor. On hospital day 3, she develops atrial fibrillation with rapid ventricular response. CHA2DS2-VASc score is 4. Creatinine is normal. Evaluate the optimal antithrombotic strategy balancing ischemic and bleeding risk.
Q3
A 60-year-old man with inferoposterior STEMI presents to a rural hospital. The nearest PCI-capable facility is 3 hours away. He arrives 90 minutes after symptom onset. Blood pressure is 130/85 mmHg, heart rate 88/min, oxygen saturation 96% on room air. He has no contraindications to fibrinolysis. The transfer team can arrive in 30 minutes. Evaluate the evidence-based approach considering time metrics and available resources.
Q4
A 65-year-old man with extensive anterior STEMI underwent PCI 6 hours after symptom onset due to delayed presentation. Peak troponin was significantly elevated. Three days later, he develops progressive dyspnea. Examination reveals a new holosystolic murmur at the apex radiating to the axilla. Echocardiogram shows severe mitral regurgitation with flail posterior leaflet and hyperdynamic left ventricle. Pulmonary capillary wedge pressure tracing shows prominent v waves. He is euvolemic on examination. Analyze this complication to determine timing of intervention.
Q5
A 72-year-old man with inferior STEMI underwent successful PCI 5 days ago. He develops sudden onset dyspnea and hypotension. Blood pressure is 75/50 mmHg with pulsus paradoxus of 20 mmHg. Jugular venous pressure is elevated with prominent x descent. Emergent echocardiography shows large pericardial effusion with right atrial and ventricular diastolic collapse. The patient is on aspirin, clopidogrel, and therapeutic enoxaparin. Analyze the complication and optimal intervention strategy.
Q6
A 68-year-old woman with anterior STEMI underwent successful PCI 3 days ago. She now complains of sharp, positional chest pain relieved by sitting forward. Temperature is 38.2°C (100.8°F), blood pressure 105/70 mmHg, heart rate 98/min. Cardiac examination reveals a friction rub. ECG shows diffuse ST-segment elevation with PR depression. Troponin levels are trending down from peak values. Echocardiogram shows small pericardial effusion without tamponade. Analyze the clinical picture to determine management.
Q7
A 55-year-old man presents with acute chest pain. ECG shows ST-segment elevation in leads I, aVL, V5-V6. Emergency catheterization reveals 95% stenosis of the proximal left circumflex artery. During PCI, the patient develops ventricular fibrillation requiring defibrillation. After successful stent placement and return of sinus rhythm, he becomes confused and combative. Blood pressure is 90/60 mmHg despite vasopressors. Cardiac index is 1.8 L/min/m². Apply your knowledge to determine the appropriate hemodynamic support.
Q8
A 70-year-old man with STEMI underwent successful primary PCI to the LAD 2 hours ago. He suddenly develops severe shortness of breath and hypotension. Blood pressure is 80/50 mmHg, heart rate 110/min. Examination reveals a harsh holosystolic murmur at the left sternal border with a palpable thrill. Echocardiography shows interventricular septal rupture with left-to-right shunt. He is on maximal medical therapy. What is the most appropriate definitive management?
Q9
A 58-year-old woman with diabetes and hypertension presents with acute chest pain. ECG shows ST-segment elevation in leads II, III, and aVF. She is taken for emergent cardiac catheterization which reveals 100% occlusion of the right coronary artery. After successful stent placement, her blood pressure drops to 85/50 mmHg and heart rate is 48/min. Physical examination reveals jugular venous distention and clear lung fields. What is the most appropriate next step?
Q10
A 62-year-old man presents to the emergency department with crushing substernal chest pain radiating to his left arm for 45 minutes. ECG shows ST-segment elevation in leads V1-V4. Blood pressure is 110/70 mmHg, heart rate 92/min. The nearest cardiac catheterization facility is 90 minutes away by ambulance. What is the most appropriate immediate management?
MI US Medical PG Practice Questions and MCQs
Question 1: A 70-year-old man with diabetes, hypertension, and chronic kidney disease (eGFR 35 mL/min/1.73m²) presents with NSTEMI. Troponin is elevated at 8.5 ng/mL. ECG shows 2mm ST depression in V2-V5. GRACE score is 165 (high risk). He is hemodynamically stable. Cardiologist recommends early invasive strategy within 24 hours. Nephrologist is concerned about contrast-induced nephropathy potentially requiring dialysis. Patient is on metformin. Evaluate the management strategy integrating multiple specialist perspectives and evidence.
A. Proceed with angiography within 24 hours using iso-osmolar contrast and intravenous hydration, hold metformin (Correct Answer)
B. Perform coronary CT angiography as alternative to invasive angiography
C. Delay catheterization for 72 hours to optimize renal function with hydration
D. Prophylactic hemodialysis before and after catheterization to remove contrast
E. Medical management only with dual antiplatelet therapy, avoid catheterization
Explanation: ***Proceed with angiography within 24 hours using iso-osmolar contrast and intravenous hydration, hold metformin***
- High-risk NSTEMI patients with a **GRACE score >140** benefit from an **early invasive strategy** within 24 hours to reduce ischemic events and mortality.
- Renal protection is maximized through **pre-procedural hydration** and **iso-osmolar contrast**, while **metformin** must be held to avoid the risk of lactic acidosis if acute kidney injury occurs.
*Perform coronary CT angiography as alternative to invasive angiography*
- **Coronary CTA** is primarily used for ruling out coronary artery disease in low-to-intermediate risk stable patients, not for high-risk **NSTEMI**.
- This modality still requires **iodinated contrast** and does not provide the therapeutic benefit of percutaneous coronary intervention (**PCI**).
*Delay catheterization for 72 hours to optimize renal function with hydration*
- Delaying the procedure in a high-risk patient increases the risk of **re-infarction** and **cardiovascular death**, outweighing the minor benefits of prolonged hydration.
- Evidence suggests that optimization of renal status should happen concurrently with the preparation for **early intervention** in high-risk ACS.
*Prophylactic hemodialysis before and after catheterization to remove contrast*
- **Prophylactic hemodialysis** has not been proven to prevent contrast-induced nephropathy and may actually increase the risk of adverse events.
- High-volume **intravenous hydration** with isotonic saline remains the gold standard for preventing renal injury in patients with **CKD**.
*Medical management only with dual antiplatelet therapy, avoid catheterization*
- While **dual antiplatelet therapy** is essential, medical management alone is inferior to an invasive strategy in patients with **high GRACE scores**.
- Avoiding catheterization based solely on **renal impairment** results in "renalism," where patients are undertreated for their life-threatening cardiac condition.
Question 2: A 58-year-old woman with anterior STEMI underwent primary PCI with drug-eluting stent placement. Post-procedure echocardiogram shows left ventricular ejection fraction of 30% with apical akinesis. She is started on aspirin, ticagrelor, high-intensity statin, and ACE inhibitor. On hospital day 3, she develops atrial fibrillation with rapid ventricular response. CHA2DS2-VASc score is 4. Creatinine is normal. Evaluate the optimal antithrombotic strategy balancing ischemic and bleeding risk.
A. Triple therapy with aspirin, ticagrelor, and apixaban indefinitely
B. Triple therapy for 6 months, then aspirin and apixaban indefinitely
C. Aspirin and ticagrelor only, hold anticoagulation due to bleeding risk
D. Warfarin with INR 2-3 plus aspirin, discontinue ticagrelor
E. Triple therapy for 1 month, then apixaban and clopidogrel for 11 months, then apixaban alone (Correct Answer)
Explanation: ***Triple therapy for 1 month, then apixaban and clopidogrel for 11 months, then apixaban alone***
- In patients with **Atrial Fibrillation** (CHA2DS2-VASc ≥2) undergoing **PCI**, current guidelines recommend minimizing the duration of **triple therapy** (aspirin, P2Y12 inhibitor, and anticoagulant) to 1 week to 1 month to reduce **bleeding risk**.
- Transitioning to **dual therapy** with a **NOAC** (like apixaban) and a P2Y12 inhibitor (preferably **clopidogrel**) for up to 12 months, followed by NOAC monotherapy, provides an optimal balance between preventing **stent thrombosis** and systemic **thromboembolism**.
*Triple therapy with aspirin, ticagrelor, and apixaban indefinitely*
- Indefinite **triple therapy** carries a prohibitively high risk of life-threatening **major bleeding** without added benefit for stroke prevention.
- **Ticagrelor** is generally avoided in triple therapy regimens due to a significantly higher bleeding profile compared to **clopidogrel**.
*Triple therapy for 6 months, then aspirin and apixaban indefinitely*
- **Triple therapy** for 6 months is rarely indicated and significantly increases the risk of **gastrointestinal and intracranial hemorrhage** compared to the 1-month strategy.
- Aspirin is usually discontinued after the first year in favor of **anticoagulant monotherapy**, as the latter is sufficient for both AF and stable CAD protection.
*Aspirin and ticagrelor only, hold anticoagulation due to bleeding risk*
- This approach leaves the patient with a high **CHA2DS2-VASc score of 4** unprotected against **cardioembolic stroke**, which carries high morbidity and mortality.
- Dual antiplatelet therapy (DAPT) alone is significantly less effective than **oral anticoagulants** for stroke prevention in the setting of atrial fibrillation.
*Warfarin with INR 2-3 plus aspirin, discontinue ticagrelor*
- **NOACs** (like apixaban) are now preferred over **Warfarin** for non-valvular AF due to a superior safety profile, including a lower risk of **intracranial hemorrhage**.
- Discontinuing the P2Y12 inhibitor (ticagrelor) immediately post-PCI in favor of aspirin and warfarin significantly increases the risk of **stent thrombosis**.
Question 3: A 60-year-old man with inferoposterior STEMI presents to a rural hospital. The nearest PCI-capable facility is 3 hours away. He arrives 90 minutes after symptom onset. Blood pressure is 130/85 mmHg, heart rate 88/min, oxygen saturation 96% on room air. He has no contraindications to fibrinolysis. The transfer team can arrive in 30 minutes. Evaluate the evidence-based approach considering time metrics and available resources.
A. Immediate fibrinolytic therapy followed by transfer (Correct Answer)
B. Helicopter transfer to reduce transfer time, then primary PCI
C. Administer half-dose fibrinolytic and transfer for immediate PCI
D. Fibrinolytic therapy at rural hospital, transfer only if fails
E. Wait for transfer team and proceed directly to PCI facility
Explanation: ***Immediate fibrinolytic therapy followed by transfer***
- In a STEMI patient where the expected **door-to-balloon time** exceeds **120 minutes**, and the patient is seen within **12 hours** of symptom onset, **fibrinolytic therapy** is the preferred reperfusion strategy.
- Following fibrinolysis, a **pharmacoinvasive strategy** is recommended, involving a routine transfer to a PCI-capable center for angiography within **3 to 24 hours**.
*Helicopter transfer to reduce transfer time, then primary PCI*
- Even with expedited transport, the distance and total time likely still exceed the recommended **120-minute window** for primary PCI superiority over fibrinolysis.
- Choosing transfer over immediate thrombolysis in a rural setting when delays are significant increases the risk of **myocardial necrosis**.
*Administer half-dose fibrinolytic and transfer for immediate PCI*
- **Half-dose fibrinolytics** are generally only considered in specific subsets like elderly patients (over 75) to reduce **intracranial hemorrhage** risk, which does not apply here.
- Combining half-dose thrombolysis with immediate PCI (facilitated PCI) has not shown superior outcomes and may increase **bleeding complications**.
*Fibrinolytic therapy at rural hospital, transfer only if fails*
- Modern guidelines recommend a **pharmacoinvasive approach**, meaning all patients should be transferred for **coronary angiography** regardless of clinical success of fibrinolysis.
- Waiting only for "failure" (rescue PCI) ignores the benefit of definitive **revascularization** and stabilization provided by routine post-thrombolysis PCI.
*Wait for transfer team and proceed directly to PCI facility*
- Delaying reperfusion for a 3-hour transport window violates the "**time is muscle**" principle, as the patient is currently in the highly time-sensitive **early window** (under 3 hours).
- Failure to administer fibrinolytics when the **PCI-related delay** is over 90-120 minutes is a deviation from standard **STEMI management protocols**.
Question 4: A 65-year-old man with extensive anterior STEMI underwent PCI 6 hours after symptom onset due to delayed presentation. Peak troponin was significantly elevated. Three days later, he develops progressive dyspnea. Examination reveals a new holosystolic murmur at the apex radiating to the axilla. Echocardiogram shows severe mitral regurgitation with flail posterior leaflet and hyperdynamic left ventricle. Pulmonary capillary wedge pressure tracing shows prominent v waves. He is euvolemic on examination. Analyze this complication to determine timing of intervention.
A. Immediate surgical mitral valve repair or replacement
B. Aggressive diuresis and ACE inhibitor, reassess in 2 weeks
C. Intra-aortic balloon pump with surgery within 24-48 hours (Correct Answer)
D. Percutaneous mitral valve repair with MitraClip
E. Medical management with afterload reduction for 6 weeks, then surgery
Explanation: ***Intra-aortic balloon pump with surgery within 24-48 hours***
- **Acute papillary muscle rupture** leads to severe mitral regurgitation and hemodynamic instability; an **IABP** provides essential **afterload reduction** and increases forward flow while reducing the regurgitant fraction.
- Providing a brief period of stabilization for 24-48 hours allows for therapeutic optimization before **urgent surgical intervention**, balancing the high risk of immediate surgery with the extreme mortality of medical delay.
*Immediate surgical mitral valve repair or replacement*
- Performing surgery immediately upon diagnosis carries an exceptionally high mortality rate due to the **friable, necrotic myocardial tissue** that is difficult to suture.
- While definitive, Proceeding without initial **hemodynamic stabilization** (like IABP) increases the risk of intraoperative cardiovascular collapse.
*Aggressive diuresis and ACE inhibitor, reassess in 2 weeks*
- This patient has a mechanical complication (flail leaflet); medical management alone for **acute MR** has a mortality rate exceeding 90%.
- **ACE inhibitors** may be poorly tolerated in the acute setting of a large MI if the patient becomes hypotensive, and waiting 2 weeks is far too long for a **mechanical emergency**.
*Percutaneous mitral valve repair with MitraClip*
- **MitraClip** is primarily indicated for chronic secondary MR or in patients with prohibitive surgical risk, rather than as first-line treatment for **acute post-MI papillary muscle rupture**.
- The necrotic and distorted nature of the **subvalvular apparatus** in an acute rupture makes it a poor substrate for percutaneous repair techniques.
*Medical management with afterload reduction for 6 weeks, then surgery*
- Delaying surgery for 6 weeks for "tissue healing" is inappropriate for **papillary muscle rupture** as the patient will likely suffer from progressive **pulmonary edema** or cardiogenic shock.
- While chronic MR can be managed medically, **acute structural failure** requires urgent mechanical correction once stable, not prolonged medical therapy.
Question 5: A 72-year-old man with inferior STEMI underwent successful PCI 5 days ago. He develops sudden onset dyspnea and hypotension. Blood pressure is 75/50 mmHg with pulsus paradoxus of 20 mmHg. Jugular venous pressure is elevated with prominent x descent. Emergent echocardiography shows large pericardial effusion with right atrial and ventricular diastolic collapse. The patient is on aspirin, clopidogrel, and therapeutic enoxaparin. Analyze the complication and optimal intervention strategy.
A. Immediate surgical exploration and repair (Correct Answer)
B. Administer protamine and fresh frozen plasma, then observe
C. Discontinue anticoagulation and observe with serial echocardiograms
D. Increase intravenous fluid administration
E. Urgent pericardiocentesis followed by surgical evaluation
Explanation: ***Immediate surgical exploration and repair***
- The patient presents with **free wall rupture** leading to **cardiac tamponade**, a lethal post-MI complication typically occurring 3 to 7 days after the event.
- Definitive treatment for mechanical rupture requires **emergent surgery** to repair the defect, as conservative management carries a near 100% mortality rate.
*Administer protamine and fresh frozen plasma, then observe*
- While reversing **anticoagulation** is important, observation is inappropriate for a patient with **mechanical rupture** and obstructive shock.
- Delaying surgery for medical reversal will likely result in **cardiac arrest** due to rapid hemodynamic collapse.
*Discontinue anticoagulation and observe with serial echocardiograms*
- Discontinuing medication addresses the risk of hemorrhage but fails to manage the primary **ventricular wall defect**.
- **Serial echocardiograms** are indicated for stable pericarditis, not a patient with **hypotension** and right heart collapse.
*Increase intravenous fluid administration*
- IV fluids can be a temporary bridge to maintain **preload** during tamponade, but they are never a curative or primary strategy.
- Over-reliance on fluid resuscitation delays the necessary **surgical decompression** and defect repair required for survival.
*Urgent pericardiocentesis followed by surgical evaluation*
- While it can relieve pressure, **pericardiocentesis** is often contraindicated in free wall rupture as it can dislodge a clot and **exacerbate bleeding**.
- Immediate transition to the **operating room** is the priority over bedside drainage in the setting of post-MI mechanical complications.
Question 6: A 68-year-old woman with anterior STEMI underwent successful PCI 3 days ago. She now complains of sharp, positional chest pain relieved by sitting forward. Temperature is 38.2°C (100.8°F), blood pressure 105/70 mmHg, heart rate 98/min. Cardiac examination reveals a friction rub. ECG shows diffuse ST-segment elevation with PR depression. Troponin levels are trending down from peak values. Echocardiogram shows small pericardial effusion without tamponade. Analyze the clinical picture to determine management.
A. High-dose aspirin and colchicine therapy (Correct Answer)
B. High-dose corticosteroids
C. Resume dual antiplatelet therapy with clopidogrel
D. Initiate systemic anticoagulation with heparin
E. Urgent pericardiocentesis
Explanation: ***High-dose aspirin and colchicine therapy***
- The patient is experiencing **peri-infarction pericarditis**, occurring within days of a STEMI, characterized by **pleuritic chest pain**, a **pericardial friction rub**, and diffuse **ST-segment elevation**.
- **High-dose aspirin** is the preferred anti-inflammatory post-MI as other **NSAIDs** can interfere with myocardial healing and increase the risk of myocardial rupture.
*High-dose corticosteroids*
- **Corticosteroids** are generally avoided in the early post-MI period because they are associated with **impaired scar formation** and an increased risk of **ventricular free wall rupture**.
- They are typically reserved for patients who fail to respond to first-line therapies like aspirin and colchicine.
*Resume dual antiplatelet therapy with clopidogrel*
- While the patient should already be on **dual antiplatelet therapy (DAPT)** following PCI, DAPT alone does not provide the **high-dose anti-inflammatory** effect needed to treat pericarditis.
- Escalating or resuming maintenance doses of clopidogrel will not resolve the **pericardial inflammation** or the associated pain.
*Initiate systemic anticoagulation with heparin*
- Systemic **anticoagulation** is generally avoided in patients with acute pericarditis because it increases the risk of developing **hemorrhagic pericardial effusion**.
- This can lead to rapid **cardiac tamponade**, especially in the setting of recent myocardial injury.
*Urgent pericardiocentesis*
- **Pericardiocentesis** is only indicated for patients with **cardiac tamponade** or for diagnostic purposes in suspected purulent/malignant effusions.
- Since the echocardiogram shows only a **small effusion** without hemodynamic compromise (tamponade), this invasive procedure is not required.
Question 7: A 55-year-old man presents with acute chest pain. ECG shows ST-segment elevation in leads I, aVL, V5-V6. Emergency catheterization reveals 95% stenosis of the proximal left circumflex artery. During PCI, the patient develops ventricular fibrillation requiring defibrillation. After successful stent placement and return of sinus rhythm, he becomes confused and combative. Blood pressure is 90/60 mmHg despite vasopressors. Cardiac index is 1.8 L/min/m². Apply your knowledge to determine the appropriate hemodynamic support.
A. Initiate intra-aortic balloon pump counterpulsation (Correct Answer)
B. Increase inotropic support with milrinone
C. Start additional vasopressor therapy with norepinephrine
D. Emergent venoarterial extracorporeal membrane oxygenation
E. Place Impella left ventricular assist device
Explanation: ***Initiate intra-aortic balloon pump counterpulsation***
- This patient is in **cardiogenic shock** following a lateral wall myocardial infarction, characterized by a low **cardiac index** (<2.2 L/min/m²) and hypotension despite pharmacologic support.
- An **intra-aortic balloon pump (IABP)** is the first-line mechanical support here as it provides **diastolic augmentation** to improve coronary perfusion and decreases **afterload** (wall stress) to reduce myocardial oxygen demand.
*Increase inotropic support with milrinone*
- **Milrinone** acts as a vasodilator (inodilator) which can worsen systemic **hypotension** in a patient whose blood pressure is already 90/60 mmHg.
- While it improves contractility, it does not provide the **mechanical afterload reduction** necessary to stabilize a patient failing high-dose vasopressors.
*Start additional vasopressor therapy with norepinephrine*
- Adding more **vasopressors** increases systemic vascular resistance, which significantly raises **left ventricular afterload** and myocardial oxygen consumption in an already failing heart.
- High-dose vasopressors can also provoke further **arrhythmias** and contribute to end-organ ischemia by causing excessive peripheral vasoconstriction.
*Emergent venoarterial extracorporeal membrane oxygenation*
- **VA-ECMO** provides total circulatory and respiratory support but is typically reserved for **refractory cardiogenic shock** or cardiac arrest when other measures fail.
- It is a highly invasive procedure with a high risk of complications like **bleeding** and **limb ischemia**, making it a later-tier intervention than the IABP.
*Place Impella left ventricular assist device*
- The **Impella** provides superior hemodynamic support compared to IABP by directly unloading the ventricle, but it is often reserved for more **profound shock** or high-risk PCI scenarios.
- In many clinical pathways, **IABP** remains a primary initial mechanical consideration due to its lower cost, ease of insertion, and reduced risk of major vascular complications compared to the larger-bore Impella catheters.
Question 8: A 70-year-old man with STEMI underwent successful primary PCI to the LAD 2 hours ago. He suddenly develops severe shortness of breath and hypotension. Blood pressure is 80/50 mmHg, heart rate 110/min. Examination reveals a harsh holosystolic murmur at the left sternal border with a palpable thrill. Echocardiography shows interventricular septal rupture with left-to-right shunt. He is on maximal medical therapy. What is the most appropriate definitive management?
A. Increase inotropic support and continue medical management
B. Heart transplantation evaluation
C. Place intra-aortic balloon pump and delay surgery for 6 weeks
D. Percutaneous closure of ventricular septal defect
E. Immediate surgical repair of ventricular septal defect (Correct Answer)
Explanation: ***Immediate surgical repair of ventricular septal defect***
- **Ventricular septal rupture (VSR)** is a mechanical complication of myocardial infarction that leads to **cardiogenic shock**; immediate surgery is the only definitive treatment to correct the shunt.
- Despite a high operative mortality rate (20-50%), a surgical approach is prioritized over medical stabilization because the patient's condition will likely undergo **progressive hemodynamic deterioration** without it.
*Increase inotropic support and continue medical management*
- While **inotropes** can help maintain perfusion temporarily, they do not address the underlying **mechanical defect** causing the left-to-right shunt.
- Medical management alone for acute VSR is associated with an extremely high mortality rate, approaching **90% within weeks**.
*Heart transplantation evaluation*
- **Heart transplantation** is not an appropriate first-line treatment for an acute mechanical complication following a **STEMI**.
- The patient requires **emergent intervention** to survive the acute phase of cardiogenic shock, which transplant protocols cannot accommodate.
*Place intra-aortic balloon pump and delay surgery for 6 weeks*
- An **intra-aortic balloon pump (IABP)** is useful as a bridge to stabilize the patient, but delaying surgery for 6 weeks is only feasible for **hemodynamically stable** patients.
- In a patient with hypotension and severe symptoms, delaying surgery increases the risk of **multiorgan failure** and death.
*Percutaneous closure of ventricular septal defect*
- **Percutaneous closure** is generally considered investigational or reserved for patients with small defects or those who are **very high-risk surgical candidates**.
- The gold standard for acute, large ruptures causing significant shunting at the left sternal border remains **open surgical repair**.
Question 9: A 58-year-old woman with diabetes and hypertension presents with acute chest pain. ECG shows ST-segment elevation in leads II, III, and aVF. She is taken for emergent cardiac catheterization which reveals 100% occlusion of the right coronary artery. After successful stent placement, her blood pressure drops to 85/50 mmHg and heart rate is 48/min. Physical examination reveals jugular venous distention and clear lung fields. What is the most appropriate next step?
A. Immediate fluid resuscitation with normal saline bolus (Correct Answer)
B. Emergent echocardiography to assess left ventricular function
C. Administer intravenous atropine
D. Place intra-aortic balloon pump
E. Start inotropic support with dobutamine
Explanation: ***Immediate fluid resuscitation with normal saline bolus***
- This patient presents with an **inferior wall myocardial infarction** and a **right ventricular (RV) infarction**, characterized by the triad of **hypotension**, **jugular venous distention (JVD)**, and **clear lung fields**.
- RV failure leads to decreased **preload** for the left ventricle; therefore, aggressive **intravenous fluid resuscitation** is the first-line treatment to improve cardiac output.
*Emergent echocardiography to assess left ventricular function*
- While an echocardiogram can confirm RV dysfunction, it should not delay life-saving **volume resuscitation** in an unstable patient.
- The **clear lung fields** already clinicaly suggest that the primary issue is not left ventricular failure or pulmonary edema.
*Administer intravenous atropine*
- Although the patient is bradycardic, the primary driver of hypotension in RV infarction is usually **decreased preload** rather than heart rate alone.
- Atropine may be useful if bradycardia persists, but it does not address the **volume-dependent** state of the infarcted right ventricle.
*Place intra-aortic balloon pump*
- An IABP is typically used for **cardiogenic shock** resulting from left ventricular failure or mechanical complications like mitral regurgitation.
- It is not the initial treatment for RV infarction and is generally ineffective for isolated right-sided heart failure.
*Start inotropic support with dobutamine*
- Inotropic support should only be considered if the patient remains hypotensive **after adequate fluid loading**.
- Starting inotropes before ensuring adequate **preload** can be ineffective and potentially worsen the clinical status.
Question 10: A 62-year-old man presents to the emergency department with crushing substernal chest pain radiating to his left arm for 45 minutes. ECG shows ST-segment elevation in leads V1-V4. Blood pressure is 110/70 mmHg, heart rate 92/min. The nearest cardiac catheterization facility is 90 minutes away by ambulance. What is the most appropriate immediate management?
A. Administer fibrinolytic therapy and transfer for catheterization
B. Administer nitroglycerin and delay transfer until pain resolves
C. Administer aspirin, heparin, and observe in emergency department
D. Perform emergent coronary artery bypass grafting
E. Arrange immediate transfer for primary percutaneous coronary intervention (Correct Answer)
Explanation: ***Arrange immediate transfer for primary percutaneous coronary intervention***
- For a patient with an **ST-segment elevation myocardial infarction (STEMI)**, the preferred reperfusion strategy is **primary PCI** if it can be performed within **120 minutes** of first medical contact.
- Since the nearest facility is **90 minutes** away, the patient falls within the window where PCI is superior to fibrinolytics in reducing **mortality, reinfarction, and hemorrhagic stroke**.
*Administer fibrinolytic therapy and transfer for catheterization*
- **Fibrinolytic therapy** is generally reserved for STEMI patients when the expected delay to **primary PCI** exceeds 120 minutes from the time of diagnosis.
- Administering fibrinolytics when timely PCI is available increases the risk of **major bleeding** without the superior outcomes of mechanical revascularization.
*Administer nitroglycerin and delay transfer until pain resolves*
- **Nitroglycerin** helps with symptom relief and reduces preload but does not achieve **reperfusion** or treat the underlying coronary occlusion.
- Delaying transfer for a STEMI patient is contraindicated as **time is myocardium**, and delays lead to irreversible **myocyte necrosis** and heart failure.
*Administer aspirin, heparin, and observe in emergency department*
- While **aspirin** and **heparin** are essential adjunctive treatments, observation alone is insufficient for a STEMI, which requires emergent **revascularization**.
- Observation without definitive intervention allows leads to a higher risk of **ventricular arrhythmias**, cardiogenic shock, and death.
*Perform emergent coronary artery bypass grafting*
- **CABG** is not the first-line treatment for acute STEMI unless there is **mechanical complication** (e.g., papillary muscle rupture) or failed PCI with persistent ischemia.
- It is a highly invasive surgical procedure that would delay necessary reperfusion significantly compared to **percutaneous intervention**.
